Literature DB >> 14749036

Functional significance of gastrin gene expression in human cancer cells.

Jill P Smith1, Michael F Verderame, Elizabeth N Ballard, Ian S Zagon.   

Abstract

The gastrointestinal peptide, gastrin, stimulates the growth of human pancreatic cancer. A receptor for gastrin activity, the cholecystokinin-C (CCK-C) receptor, has been identified in binding assays, cloned and sequenced, and is a splice variant of the CCK-B receptor. The relationship of gastrin and the CCK-C receptor to the growth of cancer cells was examined in vitro and in vivo. Stable transfection of the sense cDNA of gastrin into human MDA Amp-7 ampullary cancer cells, which normally lack gastrin gene expression but possess CCK-C receptors, increased cell growth up to 10-fold over wild type (WT) and vector-transfected (VT) cells. MDA Amp-7 tumors of gastrin-transfected cells reduced latency time for a visible tumor by 35%, decreased the timetable of tumor incidence, and increased tumor size by at least 2-fold in comparison to WT and VT groups. Transfection of human BxPC-3 pancreatic cancer cells, which normally express gastrin and possess CCK-C receptors, with the antisense cDNA to human gastrin decreased cell number by 30% in culture and tumor size by 53% compared to the WT and VT groups. Transfection of sense gastrin cDNA to monkey COS-1 cells, which normally lack both the gastrin and the CCK-C receptor genes, had no effect on growth. These studies demonstrate that gastrin and the CCK-C receptor form an autocrine loop in human pancreatic cancer that plays a role in regulating growth.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14749036     DOI: 10.1016/j.regpep.2003.10.013

Source DB:  PubMed          Journal:  Regul Pept        ISSN: 0167-0115


  12 in total

1.  Progastrin overexpression imparts tumorigenic/metastatic potential to embryonic epithelial cells: phenotypic differences between transformed and nontransformed stem cells.

Authors:  Shubhashish Sarkar; Carla Kantara; Ixiu Ortiz; Rafal Swiercz; Joyce Kuo; Robert Davey; Kenneth Escobar; Robert Ullrich; Pomila Singh
Journal:  Int J Cancer       Date:  2012-05-17       Impact factor: 7.396

Review 2.  Cholecystokinin and pancreatic cancer: the chicken or the egg?

Authors:  Jill P Smith; Travis E Solomon
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2013-10-31       Impact factor: 4.052

3.  Bioconjugation of calcium phosphosilicate composite nanoparticles for selective targeting of human breast and pancreatic cancers in vivo.

Authors:  Brian M Barth; Rahul Sharma; Erhan I Altinoğlu; Thomas T Morgan; Sriram S Shanmugavelandy; James M Kaiser; Christopher McGovern; Gail L Matters; Jill P Smith; Mark Kester; James H Adair
Journal:  ACS Nano       Date:  2010-03-23       Impact factor: 15.881

Review 4.  Role of gastrointestinal hormones in neuroblastoma.

Authors:  W Clay Gustafson; Brittany B De Berry; B Mark Evers; Dai H Chung
Journal:  World J Surg       Date:  2005-03       Impact factor: 3.352

5.  Construction and evaluation of anti-gastrin immunogen based on P64K protein.

Authors:  Xiang-Hua Xiong; Hong-Liang Zhao; Chong Xue; Wei Zhang; Bing-Fen Yang; Xue-Qin Yao; Zhi-Min Liu
Journal:  World J Gastroenterol       Date:  2006-04-07       Impact factor: 5.742

Review 6.  Gastrin: old hormone, new functions.

Authors:  Graham Dockray; Rod Dimaline; Andrea Varro
Journal:  Pflugers Arch       Date:  2004-10-05       Impact factor: 3.657

Review 7.  KRAS, YAP, and obesity in pancreatic cancer: A signaling network with multiple loops.

Authors:  Guido Eibl; Enrique Rozengurt
Journal:  Semin Cancer Biol       Date:  2017-10-24       Impact factor: 15.707

8.  Growth of human pancreatic cancer is inhibited by down-regulation of gastrin gene expression.

Authors:  Gail L Matters; John F Harms; Christopher O McGovern; Calpurnia Jayakumar; Keisha Crepin; Zachary P Smith; Melissa C Nelson; Heather Stock; Craig W Fenn; James Kaiser; Mark Kester; Jill P Smith
Journal:  Pancreas       Date:  2009-07       Impact factor: 3.327

9.  Use of interfering RNA to investigate the role of endogenous gastrin in the survival of gastrointestinal cancer cells.

Authors:  A M Grabowska; J Hughes; S A Watson
Journal:  Br J Cancer       Date:  2007-01-30       Impact factor: 7.640

10.  Gastrazole (JB95008), a novel CCK2/gastrin receptor antagonist, in the treatment of advanced pancreatic cancer: results from two randomised controlled trials.

Authors:  I Chau; D Cunningham; C Russell; A R Norman; T Kurzawinski; P Harper; P Harrison; G Middleton; F Daniels; T Hickish; J Prendeville; P J Ross; B Theis; R Hull; M Walker; N Shankley; B Kalindjian; G Murray; A Gillbanks; J Black
Journal:  Br J Cancer       Date:  2006-04-24       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.